ARS Pharmaceuticals Inc
NASDAQ:SPRY

Watchlist Manager
ARS Pharmaceuticals Inc Logo
ARS Pharmaceuticals Inc
NASDAQ:SPRY
Watchlist
Price: 11.18 USD -1.24% Market Closed
Market Cap: 1.1B USD
Have any thoughts about
ARS Pharmaceuticals Inc?
Write Note

Intrinsic Value

The intrinsic value of one SPRY stock under the Base Case scenario is 12.05 USD. Compared to the current market price of 11.18 USD, ARS Pharmaceuticals Inc is Undervalued by 7%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

SPRY Intrinsic Value
12.05 USD
Undervaluation 7%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
ARS Pharmaceuticals Inc

Intrinsic Value History
Dive into the past to invest in the future

Uncover deeper insights with the Valuation History. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start now and learn if your stock is truly undervalued or overvalued!

Start Valuation
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Valuation History Unavailable

Historical valuation for SPRY cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
How do you feel about SPRY?
Bearish
Neutral
Bullish

Fundamental Analysis

11.18 USD
-1.24%
-1.24%
Benchmark
Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

ARS Pharmaceuticals Inc
US
Biotechnology
Market Cap
1.1B USD
IPO
Dec 4, 2020
Employees
90
United States of America
Market Cap
1.1B USD
Industry
Biotechnology
IPO
Dec 4, 2020
Company Overview
Loading...
Business Segments
Loading...
Economic Moat
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
AI Assistant
AI Assistant
Ask me anything about ARS Pharmaceuticals Inc

Provide an overview of the primary business activities
of ARS Pharmaceuticals Inc.

What unique competitive advantages
does ARS Pharmaceuticals Inc hold over its rivals?

What risks and challenges
does ARS Pharmaceuticals Inc face in the near future?

Has there been any significant insider trading activity
in ARS Pharmaceuticals Inc recently?

Summarize the latest earnings call
of ARS Pharmaceuticals Inc.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for ARS Pharmaceuticals Inc.

Provide P/S
for ARS Pharmaceuticals Inc.

Provide P/E
for ARS Pharmaceuticals Inc.

Provide P/OCF
for ARS Pharmaceuticals Inc.

Provide P/FCFE
for ARS Pharmaceuticals Inc.

Provide P/B
for ARS Pharmaceuticals Inc.

Provide EV/S
for ARS Pharmaceuticals Inc.

Provide EV/GP
for ARS Pharmaceuticals Inc.

Provide EV/EBITDA
for ARS Pharmaceuticals Inc.

Provide EV/EBIT
for ARS Pharmaceuticals Inc.

Provide EV/OCF
for ARS Pharmaceuticals Inc.

Provide EV/FCFF
for ARS Pharmaceuticals Inc.

Provide EV/IC
for ARS Pharmaceuticals Inc.

Show me price targets
for ARS Pharmaceuticals Inc made by professional analysts.

What are the Revenue projections
for ARS Pharmaceuticals Inc?

How accurate were the past Revenue estimates
for ARS Pharmaceuticals Inc?

What are the Net Income projections
for ARS Pharmaceuticals Inc?

How accurate were the past Net Income estimates
for ARS Pharmaceuticals Inc?

What are the EPS projections
for ARS Pharmaceuticals Inc?

How accurate were the past EPS estimates
for ARS Pharmaceuticals Inc?

What are the EBIT projections
for ARS Pharmaceuticals Inc?

How accurate were the past EBIT estimates
for ARS Pharmaceuticals Inc?

Compare the revenue forecasts
for ARS Pharmaceuticals Inc with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of ARS Pharmaceuticals Inc and its key competitors using the latest financial data.

Compare historical revenue growth rates
of ARS Pharmaceuticals Inc against its competitors.

Analyze the profit margins
(gross, operating, and net) of ARS Pharmaceuticals Inc compared to its peers.

Compare the P/E ratios
of ARS Pharmaceuticals Inc against its peers.

Discuss the investment returns and shareholder value creation
comparing ARS Pharmaceuticals Inc with its peers.

Analyze the financial leverage
of ARS Pharmaceuticals Inc compared to its main competitors.

Show all profitability ratios
for ARS Pharmaceuticals Inc.

Provide ROE
for ARS Pharmaceuticals Inc.

Provide ROA
for ARS Pharmaceuticals Inc.

Provide ROIC
for ARS Pharmaceuticals Inc.

Provide ROCE
for ARS Pharmaceuticals Inc.

Provide Gross Margin
for ARS Pharmaceuticals Inc.

Provide Operating Margin
for ARS Pharmaceuticals Inc.

Provide Net Margin
for ARS Pharmaceuticals Inc.

Provide FCF Margin
for ARS Pharmaceuticals Inc.

Show all solvency ratios
for ARS Pharmaceuticals Inc.

Provide D/E Ratio
for ARS Pharmaceuticals Inc.

Provide D/A Ratio
for ARS Pharmaceuticals Inc.

Provide Interest Coverage Ratio
for ARS Pharmaceuticals Inc.

Provide Altman Z-Score Ratio
for ARS Pharmaceuticals Inc.

Provide Quick Ratio
for ARS Pharmaceuticals Inc.

Provide Current Ratio
for ARS Pharmaceuticals Inc.

Provide Cash Ratio
for ARS Pharmaceuticals Inc.

What is the historical Revenue growth
over the last 5 years for ARS Pharmaceuticals Inc?

What is the historical Net Income growth
over the last 5 years for ARS Pharmaceuticals Inc?

What is the current Free Cash Flow
of ARS Pharmaceuticals Inc?

Discuss the annual earnings per share (EPS)
trend over the past five years for ARS Pharmaceuticals Inc.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
ARS Pharmaceuticals Inc

Current Assets 208.8m
Cash & Short-Term Investments 204.6m
Receivables 1.2m
Other Current Assets 2.9m
Non-Current Assets 8.8m
PP&E 935k
Intangibles 7.5m
Other Non-Current Assets 377k
Current Liabilities 16.6m
Accounts Payable 11.7m
Accrued Liabilities 5m
Efficiency

Earnings Waterfall
ARS Pharmaceuticals Inc

Revenue
2.6m USD
Cost of Revenue
-612k USD
Gross Profit
2m USD
Operating Expenses
-62.5m USD
Operating Income
-60.5m USD
Other Expenses
11.4m USD
Net Income
-49.1m USD

Free Cash Flow Analysis
ARS Pharmaceuticals Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

SPRY Profitability Score
Profitability Due Diligence

ARS Pharmaceuticals Inc's profitability score is 24/100. The higher the profitability score, the more profitable the company is.

Exceptional Revenue Growth Forecast
Exceptional 1-Year Revenue Growth
ROE is Increasing
Positive Gross Profit
24/100
Profitability
Score

ARS Pharmaceuticals Inc's profitability score is 24/100. The higher the profitability score, the more profitable the company is.

SPRY Solvency Score
Solvency Due Diligence

ARS Pharmaceuticals Inc's solvency score is 81/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Short-Term Solvency
Long-Term Solvency
Low D/E
81/100
Solvency
Score

ARS Pharmaceuticals Inc's solvency score is 81/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

SPRY Price Targets Summary
ARS Pharmaceuticals Inc

Wall Street analysts forecast SPRY stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for SPRY is 29.58 USD with a low forecast of 26.26 USD and a high forecast of 36.75 USD.

Lowest
Price Target
26.26 USD
135% Upside
Average
Price Target
29.58 USD
165% Upside
Highest
Price Target
36.75 USD
229% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for SPRY?

Click here to dive deeper.

Dividends

ARS Pharmaceuticals Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for SPRY is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

SPRY Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

SPRY News

Other Videos

See Also

Discover More
What is the Intrinsic Value of one SPRY stock?

The intrinsic value of one SPRY stock under the Base Case scenario is 12.05 USD.

Is SPRY stock undervalued or overvalued?

Compared to the current market price of 11.18 USD, ARS Pharmaceuticals Inc is Undervalued by 7%.

Back to Top